Data / Form D filings / Vapogenix, Inc.
Vapogenix, Inc.: Form D filings
Vapogenix, Inc., a pharmaceuticals company in Houston, TX, filed 4 Form D notices with the SEC between 2014 and 2018. The latest, on January 11, 2018, reports $1.6 million sold of a $1.6 million offering to 7 investors.
Find out what Vapogenix, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8285 EL RIO ST., SUITE 170, Houston, TX, 77054
- Phone
- 713-748-3903 X224
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1628848
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 11, 2018 | New notice | $1,633,764 | $1,633,764 | $0 | 7 | Dec 29, 2017 | sec.gov |
| Dec 8, 2016 | Amendment | $8,612,917 | $8,203,133 | $409,784 | 37 | Aug 31, 2016 | sec.gov |
| Sep 14, 2016 | New notice | $8,612,917 | $7,978,130 | $634,787 | 35 | Aug 31, 2016 | sec.gov |
| Dec 23, 2014 | New notice | $2,100,000 | $2,100,000 | $0 | 18 | Dec 8, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| George Davitt | Director | |
| Bruce Given | Director | |
| Christopher Jorgensen | Director | |
| Marc Loev | Director | |
| Motter Clarice | Executive Officer |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Jan 8, 2018 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Vapogenix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.